Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis

OBJECTIVE: To establish the non-inferior efficacy of vonoprazan versus lansoprazole in the treatment of Asian patients with erosive oesophagitis (EO). DESIGN: In this phase III, double-blind, multicentre study, patients with endoscopically confirmed EO were randomised 1:1 to receive vonoprazan 20 mg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gut
Autors principals: Xiao, Yinglian, Zhang, Shutian, Dai, Ning, Fei, Guijun, Goh, Khean-Lee, Chun, Hoon Jai, Sheu, Bor-Shyang, Chong, Chui Fung, Funao, Nobuo, Zhou, Wen, Chen, Minhu
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Oesophagus
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6984055/
https://ncbi.nlm.nih.gov/pubmed/31409606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2019-318365
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars